<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04780607</url>
  </required_header>
  <id_info>
    <org_study_id>MARS</org_study_id>
    <nct_id>NCT04780607</nct_id>
  </id_info>
  <brief_title>Outcomes of Mitral Valve Surgery in Patients Affected by Rheumatic Heart Disease</brief_title>
  <official_title>Multicenter Results of Mitral Valve Surgery in Patients With Rheumatic Heart Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Beijing Anzhen Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Beijing Anzhen Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      rheumatic heart disease remains the majority valvular disease in low and middle income&#xD;
      countries, which mostly affected mitral valve, surgical treatment is the most effective&#xD;
      strategy to improve the outcomes of middle or late-stage RHD patient, however, whether mitral&#xD;
      valve repair surgery is superior to replacement or other evolving interventional device&#xD;
      remains controversial, this study aims to investigate the results of repair surgery compared&#xD;
      with replacement or other treatment strategy from international multicenters.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 1, 2011</start_date>
  <completion_date type="Anticipated">April 1, 2024</completion_date>
  <primary_completion_date type="Anticipated">January 1, 2024</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>10 Years</target_duration>
  <primary_outcome>
    <measure>all-cause mortality</measure>
    <time_frame>2011-2024</time_frame>
    <description>death from any cause</description>
  </primary_outcome>
  <enrollment type="Anticipated">4000</enrollment>
  <condition>Outcomes of Mitral Valve Surgery in Patients Affected by Rheumatic Heart Disease</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>mitral valve repair</intervention_name>
    <description>different repair techniques to construct rheumatic mitral valve lesion</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        1. patients with rheumatic heart disease&#xD;
&#xD;
          2. mitral valve disease&#xD;
&#xD;
          3. patients underwent initial mitral valve surgery or intervention&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  1、rheumatic heart disease 2、mitral valve disease 3、combined with other heart valve&#xD;
             disease(aortic valve, tricuspid valve, pulmonary valve) 4、patients underwent initial&#xD;
             mitral valve surgery or intervention&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  1、congenital heart disease degenerative heart valve disease 2、isolated aortic valve or&#xD;
             tricuspid valve, pulmonary valve disease( doesn't affect mitral valve ) 3、patients&#xD;
             received more than 1 time mitral valve operation&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>xu meng, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Beijing Anzhen Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>xu meng, MD</last_name>
    <email>mengxu191116@163.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>jintao fu, MD, postdoctor</last_name>
    <email>doctorfu0709@126.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Beijing Anzhen Hospital</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100086</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>xu meng, MD</last_name>
      <email>mengxu191116@163.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>March 1, 2021</study_first_submitted>
  <study_first_submitted_qc>March 1, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">March 3, 2021</study_first_posted>
  <last_update_submitted>March 1, 2021</last_update_submitted>
  <last_update_submitted_qc>March 1, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 3, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Beijing Anzhen Hospital</investigator_affiliation>
    <investigator_full_name>Xu Meng</investigator_full_name>
    <investigator_title>NO.9 department of Cardiac surgery center</investigator_title>
  </responsible_party>
  <keyword>rheumtic heart disease</keyword>
  <keyword>mitral valve surgery</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Rheumatic Heart Disease</mesh_term>
    <mesh_term>Rheumatic Diseases</mesh_term>
    <mesh_term>Heart Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

